- Determining Whether a Drug Should Be Classified as Hazardous in Medical Institutions
-
Seo B
- KMID: 2534672
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):39-46.
- doi: 10.56142/2022.14.1.39
Healthcare professionals are frequently exposed to hazardous drugs. Such drugs require special precautions because their inherent toxicities pose hazards to the people who handle them. The US National Institute for... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Management of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Syndrome
-
Lee SY
- KMID: 2534671
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):29-38.
- doi: 10.56142/2022.14.1.29
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse reaction characterized by fever, lymphadenopathy and multiorgan involvement. The delayed onset of symptoms makes diagnosis difficult,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Current Status of the Organizations Dedicated to Post-marketing Safety Management of Pharmaceuticals
-
Lee SM, Bae G, Hyun E, Song YK
- KMID: 2534670
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):19-28.
- doi: 10.56142/2022.14.1.19
Post-marketing safety management systems are important to ensure the safe use of pharmaceuticals. This review analyzed the current status of post-marketing safety management organizations to improve the consistency of its... -
- CITED
-
- Close
- SHARE
-
- Close
- An Overview of Multiple Drug Hypersensitivity Syndrome
-
Sohn KH
- KMID: 2534673
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):47-50.
- doi: 10.56142/2022.14.1.47
The multiple drug hypersensitivity syndrome (MDHS) is a novel condition characterized by a delayed hypersensitivity reaction to two structurally different drugs. It is important to be able to distinguish between... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology of Adverse Drug Reactions According to Health Insurance Type
-
Jeong HS, Kim HK, Chung JH, Han YJ, Cho SJ, Kim GH
- KMID: 2534677
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):79-85.
- doi: 10.56142/2022.14.1.79
Objective: This study aimed to analyze the epidemiological characteristics of adverse drug reactions (ADR) from a socioeconomic standpoint by comparing health insurance and medical aid patients. Methods: We reviewed hospital... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Expedited Reporting System for Investigational Drugs in the U .S., EU and South Korea
-
Cha JW, Rhee HE, Park SJ, Kim S, Cho HK, Lee JE, Lee B, Shim DY, Shin JY
- KMID: 2534669
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):11-18.
- doi: 10.56142/2022.14.1.11
As the number of clinical trials conducted worldwide continues to increase, the management of safety information of investigational medicinal products used during clinical trials has become ever more important. Individual... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse Effects of Opioids and Safe Prescription for Chronic Non-Cancer Pain
-
Lee JC, Chang DJ, Song HJ
- KMID: 2534668
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):1-10.
- doi: 10.56142/2022.14.1.1
Chronic non-cancer pain (CNCP) affects approximately 20% of the general population and its global prevalence is increasing. CNCP affects the quality of life (QOL) of both the patients and their... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Utilization of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation in the Elderly
-
Hwang H, Jung M, Choo E, Lee S
- KMID: 2534676
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):69-78.
- doi: 10.56142/2022.14.1.69
Objective: The prescription rates for oral anticoagulants (OACs) are increasing, and concerns for the risk of major bleeding in non-valvular atrial fibrillation (NVAF) patients are also on the rise. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Clostridium difficile Infection in Antibiotic Use Inpatients Based on Common Data Model
-
Moon SH, Kim HH, Nam DH, Moon Y, Kang MG, Choi IY, Byeon Sj, Yang HJ, Kim SH, Kim K, Kang DY
- KMID: 2534678
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):86-92.
- doi: 10.56142/2022.14.1.86
Objective: Clostridium difficile infection (CDI) is affected by various factors. The association between CDI and antibiotic use is well known, and proton pump inhibitors (PPI) and histamine H2 receptor antagonist... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study
-
Kang SW, Park SJ, Lee JH, Lee YS, Min MS
- KMID: 2534674
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):51-57.
- doi: 10.56142/2022.14.1.51
Objective: This study evaluated the safety of aspirin-prasugrel (AP) compared to aspirin-ticagrelor (AT) with regards to uric acid (UA) elevation among patients with acute coronary syndrome. Methods: Retrospective analyses of... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Fluoroquinolone Adverse Drug Reaction Reported in a Single Center
-
Kim HJ, Hwang S, Kim HH, Jang JY, Suh JH, Kang DY, Lee JY, Kang HR
- KMID: 2534679
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):93-99.
- doi: 10.56142/2022.14.1.93
Objective: With the increased use of fluoroquinolone in the clinical setting, adverse drug reactions (ADR) to fluoroquinolones are also on the rise. The purpose of this study was to analyze... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Re-examination System of New Drugs: A Safety Monitoring Study using Real-World Data on Re-examined Drugs
-
Kim MS, Jeong NY, Kim Y, Choi NK
- KMID: 2534675
- J Pharmacoepidemiol Risk Manage.
- 2022 Mar;14(1):58-68.
- doi: 10.56142/2022.14.1.58
Objective: Although the re-examination of the safety profiles of approved drugs including the Drug Use-Results Survey (DURS) is conducted in Korea, the evaluation process is limited due to insufficient data... -
- CITED
-
- Close
- SHARE
-
- Close
